Patents Assigned to Lhotse Bio, Inc.
  • Compounds and compositions for treating conditions associated with LPA receptor activity
    Patent number: 11884627
    Abstract: The present disclosure provides LPA antagonists, as well as pharmaceutical compositions comprising the compounds disclosed herein. Also provided are methods for treating LPA-associated diseases, disorders, and conditions.
    Type: Grant
    Filed: May 23, 2023
    Date of Patent: January 30, 2024
    Assignee: Lhotse Bio, Inc.
    Inventors: Wei Huang, Hui Lei, Zhongmiao Xu, Haizhen Zhang, Qiong Zhang
  • COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH LPA RECEPTOR ACTIVITY
    Publication number: 20240018102
    Abstract: This disclosure relates to LPA antagonists of Formula (I): including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Application
    Filed: October 21, 2021
    Publication date: January 18, 2024
    Applicant: Lhotse Bio, Inc
    Inventors: Haizhen Zhang, Michael Hanson, Andrew Jennings, Hui Lei, Xichen Lin, Qiong Zhang, Alexandre Cote, Anatoly M. Ruvinsky